首页> 外文OA文献 >Long-term analysis of LASIK for the correction of refractive errors after penetrating keratoplasty.
【2h】

Long-term analysis of LASIK for the correction of refractive errors after penetrating keratoplasty.

机译:LASIK的长期分析,用于矫正穿透性角膜移植术后的屈光不正。

摘要

PURPOSE: To determine the long-term safety and effectiveness of laser-assisted in situ keratomileusis (LASIK) in the treatment of refractive errors following penetrating keratoplasty. METHODS: A retrospective review was done of 57 eyes of 48 patients with anisometropia or high astigmatism who were unable to wear glasses or a contact lens after penetrating keratoplasty and who underwent LASIK for visual rehabilitation. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BCVA), and corneal transplant integrity were recorded before surgery as well as up to 60 months after LASIK. RESULTS: The mean follow-up after the LASIK was 21.4 +/- 14.2 months (range, 3-60 months). Mean preoperative spherical equivalent (SE) was -4.19 +/- 3.38 diopters (D). Mean preoperative astigmatism was 4.67 +/- 2.18 D. Preoperative BCVA was 20/40 or better in 42 eyes (74%). At 2 years the mean SE was -0.61 +/- 1.81 D and mean astigmatism was 1.94 +/- 1.35 D for the 28 eyes with follow-up. UCVA was 20/40 or better in 12 eyes (43%), and BCVA was 20/40 or better in 24 eyes (86%) at 2 years. A gain in BCVA of one line or more was seen in eight eyes (29%). Two eyes (7%) had loss of two or more lines of BCVA at 2 years. Nine eyes (16%) developed epithelial ingrowth. Five eyes (9%) in this series had repeat corneal transplants. CONCLUSIONS: LASIK is effective for reducing ametropia after penetrating keratoplasty. Proper patient counseling is necessary because the results of LASIK after penetrating keratoplasty are not as good as, and complications are more frequent than, in eyes with naturally occurring myopia and astigmatism. Complications are especially common in patients with mismatch of the donor and host cornea and in those with poor endothelial cell function.
机译:目的:确定激光辅助原位角膜磨镶术(LASIK)治疗穿透性角膜移植术后屈光不正的长期安全性和有效性。方法:回顾性分析48例屈光参差或高度散光的患者的57只眼睛,这些患者在穿透性角膜移植术后无法配戴眼镜或隐形眼镜,并接受了LASIK手术以进行视觉康复。术前以及术后LASIK术后60个月记录未矫正视力(UCVA),最佳眼镜矫正视力(BCVA)和角膜移植完整性。结果:LASIK术后平均随访时间为21.4 +/- 14.2个月(范围3-60个月)。术前平均等效球镜度(SE)为-4.19 +/- 3.38屈光度(D)。术前平均散光为4.67 +/- 2.18D。42眼(74%)的术前BCVA为20/40或更好。在2年时,随访28眼的平均SE为-0.61 +/- 1.81 D,平均散光为1.94 +/- 1.35D。两年后,UCVA在12眼中占20/40或更高(43%),而BCVA在24眼中占20/40或更高(86%)。用八只眼(29%)观察到BCVA增加一线或更多。 2年时,两只眼睛(7%)失去了两行或更多行BCVA。九只眼(占16%)出现了上皮向内生长。该系列中有五只眼(9%)进行了重复角膜移植。结论LASIK可有效减少穿透性角膜移植术后屈光不正。有必要进行适当的患者咨询,因为穿透性角膜移植术后的LASIK结果不如自然发生近视和散光的眼睛好,并且并发症的发生率更高。并发症在供体和宿主角膜不匹配的患者以及内皮细胞功能较差的患者中尤其常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号